You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

SYSTEMATIC REVIEW article

Front. Psychiatry

Sec. Public Mental Health

Algorithm-guided treatment for major depressive disorder versus treatment as usual: a systematic review

  • 1. Department of Psychiatry, Aalborg University Hospital, Aalborg, Denmark

  • 2. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

  • 3. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

  • 4. Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Copenhagen, Denmark

  • 5. Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

  • 6. Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom

The final, formatted version of the article will be published soon.

Abstract

A substantial proportion of patients with major depressive disorder do not remit after the initial pharmacological treatment, and a major obstacle is that progression to subsequent treatment steps often occurs too slowly, highlighting the need for more structured and effective therapeutic strategies. Algorithm-guided treatments (AGTs) provide a systematic, stepwise framework for clinical decision-making, potentially improving acute treatment outcomes compared to treatment as usual (TAU). This systematic review, conducted according to PRISMA 2020 guidelines, evaluated randomized controlled trials (RCTs) comparing AGTs to TAU in adult patients with major depressive disorder. Databases searched included PubMed, Scopus, Embase, PsychInfo, and the Cochrane Library up to June 2025. Trials investigating adults diagnosed with major depressive disorder, utilizing clinician-rated depression scales, and with trial duration of four weeks or more were included. Seven RCTs met the This is a provisional file, not the final typeset article criteria, encompassing over 3,500 participants. Most studies demonstrated superior outcomes in participants allocated to AGT – compared to TAU, including significantly shorter time to remission, higher rates of proportion of patients with remission and response, as well as and better adherence to treatment protocols. Some studies found marginal or nonsignificant differences between interventions in some of the outcomes, particularly those involving comorbid populations. These findings suggest that implementing structured, algorithm-based treatment strategies can improve the quality and efficacy of care for patients diagnosed with major depressive disorder, supporting their wider integration into clinical practice.

Summary

Keywords

algorithm-guided treatment1, depression3, major depressivedisorder4, measurement-based care5, Systematic review6, treatment as usua2

Received

10 December 2025

Accepted

16 February 2026

Copyright

© 2026 Rkman, Ernst Nielsen, Licht, Martiny, Ritter and Asztalos. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Marton Asztalos

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics